Search - tctmd.com

Displaying 221 - 240 of 428

Sort: Relevancy | Date

News Industry News

Venclose Completes Series B Financing and Announces the Appointment of Jeffrey G. Carr, MD as Chief Medical Officer and Gregory J. Vislocky to its Board of Directors

July 11, 2018

ORBITA Redux: Lancet Correspondence Takes Talk of the Sham-Controlled PCI Trial to Further Heights

News Daily News

ORBITA Redux: Lancet Correspondence Takes Talk of the Sham-Controlled PCI Trial to Further Heights

Michael O'Riordan

July 10, 2018

Lp(a) Might Not Be Good at Predicting Incident CVD in Low-Risk Women

News Daily News

Lp(a) Might Not Be Good at Predicting Incident CVD in Low-Risk Women

Yael L. Maxwell

July 09, 2018

Rivaroxaban Offers Net Reduction in Fatal or Irreversible Events in ACS: ATLAS ACS-2 TIMI-51

News Daily News

Rivaroxaban Offers Net Reduction in Fatal or Irreversible Events in ACS: ATLAS ACS-2 TIMI-51

Michael O'Riordan

July 06, 2018

New Review Probes Possibility of CVD Prevention Without Aspirin

News Daily News

New Review Probes Possibility of CVD Prevention Without Aspirin

Michael O'Riordan

July 04, 2018

SGLT2 Inhibitors Work in Type 2 Diabetes Across Levels of CV Risk, Renal Function

News Daily News

SGLT2 Inhibitors Work in Type 2 Diabetes Across Levels of CV Risk, Renal Function

July 02, 2018

Physical Fitness Blunts the Impact of Depression on CVD Mortality

News Daily News

Physical Fitness Blunts the Impact of Depression on CVD Mortality

July 02, 2018

TCTMD’s Top 10 Most Popular Stories for June 2018

News Daily News

TCTMD’s Top 10 Most Popular Stories for June 2018

July 02, 2018

‘Doomed’ by Genetics? Lifestyle Still Matters in Preventing CVD and Diabetes

News Daily News

‘Doomed’ by Genetics? Lifestyle Still Matters in Preventing CVD and Diabetes

Yael L. Maxwell

June 29, 2018

Once Again, ISCHEMIA Trial Feels the Squeeze

News Daily News

Once Again, ISCHEMIA Trial Feels the Squeeze

Michael O'Riordan

June 29, 2018

CMS Taking Another Look at Volume Requirements for TAVR Programs

News Daily News

CMS Taking Another Look at Volume Requirements for TAVR Programs

June 28, 2018

New Estimates of Bleeding Risks May Help CVD Prevention

News Daily News

New Estimates of Bleeding Risks May Help CVD Prevention

June 27, 2018

CVD Prevention and Control Remains a Challenge in India

News Daily News

CVD Prevention and Control Remains a Challenge in India

June 26, 2018

Clinical Benefit of Lowering Lp(a) Is Proportional to Its Absolute Reduction: Mendelian Randomization Analysis

News Daily News

Clinical Benefit of Lowering Lp(a) Is Proportional to Its Absolute Reduction: Mendelian Randomization Analysis

Yael L. Maxwell

June 25, 2018

NOACs Carry Lower MI Risk vs Warfarin in Real-world Study

News Daily News

NOACs Carry Lower MI Risk vs Warfarin in Real-world Study

June 25, 2018

News Industry News

Essential Medical Announces Positive Results from The Safe Manta Clinical Trial, The First Pivotal Trial for a Dedicated Large Bore Closure Device

June 25, 2018

High-Quality TAVR: Does a Minimum Volume Requirement Still Make Sense?

News Conference News The Structural Heart Disease Summit 2018

High-Quality TAVR: Does a Minimum Volume Requirement Still Make Sense?

Michael O'Riordan

June 22, 2018

Little Impact of Medicare ACOs on Low- and High-Value Revascularization Decisions

News Daily News

Little Impact of Medicare ACOs on Low- and High-Value Revascularization Decisions

June 22, 2018

The Goal of FMR Treatment: Reduction or Elimination of MR?

Presentation The Structural Heart Disease Summit 2018

The Goal of FMR Treatment: Reduction or Elimination of MR?

Presenter: Randall C. Starling

June 21, 2018

Staffing the Structural Heart and Valve Center: The Roles of Cardiovascular Team Professionals

Presentation The Structural Heart Disease Summit 2018

Staffing the Structural Heart and Valve Center: The Roles of Cardiovascular Team Professionals

Presenter: Elizabeth M. Perpetua, Susan J. Schnell

June 21, 2018

Country

First Name

Last Name

Email

Profession

Organization

Country

CAPTCHA

This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.